Acute Kidney Injury Linked to BRAF Inhibitors in MelanomaAcute Kidney Injury Linked to BRAF Inhibitors in Melanoma

Treatment with vemurafenib and dabrafenib was associated with acute renal toxicity in patients with melanoma, according to data from the FDA Adverse Event Reporting System. Medscape Medical News
Source: Medscape Nephrology Headlines - Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news